High-dose tranylcypromine in refractory depression;HOCHDOSIERTE TRANYLCYPROMINBEHANDLUNG 'THERAPIERESISTENTER' DEPRESSIONEN

Nervenarzt

Volumn 67, Issue 5, 1996, Pages 390-393

  Schmauss M ^a  

^a Bezirkskrankenhaus   (Germany)

Author keywords

high dose tranylcypromine; refractory depression

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DOXEPIN; HALOPERIDOL; LITHIUM; MAPROTILINE; TRANYLCYPROMINE; TRIFLUOPERAZINE; MONOAMINE OXIDASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; CHRONIC DISEASE; DOSE RESPONSE; DRUG ADMINISTRATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; RECURRENCE; TRANYLCYPROMINE;

EID: 0030133809     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Amsterdam JD, Berwish NJ (1989) High dose tranylcypromine therapy for refractory depression. Pharmacopsychiatry 22: 21-25
2. Becker T (1993) Monoaminoxidase Hemmer - Praktische Durchführung und allgemeine Behandlungsrichtlinien. In: Riederer P, Laux G, Pödlinger W (Hrsg) Neuropsychopharmaka, Bd3, Antidepressiva und Phasenprophylaktika. Springer, Wien New York, S 341-348
3. Davidson JT, Miller RD, Turnbull CD et al (1982) Atypical depression. Arch Gen Psychiatry 39: 527-534
4. Dilsaver SC (1988) Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology. Acta Psychiatr Scand 78: 1-7
5. Folkerts H (1995) Elektrokrampftherapie. Dtsch Ärztebl 92: 230-235
6. Greenblatt M, Grosser FH, Wechseler H (1964) Differential response of hospitalized depressed patients to somatic therapy. Am J Psychiatry 120: 935-943
7. Griffin N, Draper RJ, Webb MGT (1981) Addiction to tranylcypromine. Br Med J 2: 346
8. Guze BH, Baxter LR jr (1987) Refractory depression treated with high doses of a monoamine oxidase inhibitor. J Clin Psychiatry 48: 31-32
9. Helmchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York, S 237-250
10. Liskin B, Roox SP, Walsh BT, Jackson WK (1985) Acute psychosis following phenelzine discontinuation. J Clin Psychopharmacol 5: 46-47
11. MacGrath PJ, Stewart JW, Harrison W, Quitkin FM (1987) Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant. Psychol Bull 23: 169-172
12. Möller HJ (1991) Therapieresistenz auf Antidepressiva: Risikofaktoren und Behandlungsmöglichkeiten. Nervenarzt 62: 658-669
13. Nolen WA, van de Putte JJ, Dijken WA, Kamp JS, Lansjaar BA, Kramer HJ, Haffmanns J (1988) Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial cross-over study on the effects of oxaprotiline and fluvoxamine. II. MAO inhibitors in depression resistant to cyclic antidepressants: Two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine. Acta Psychiatr Scand 78: 668-675, 676-683
14. Pare CMB (1985) The present status of monoamine oxidase inhibitors. Br J Psychiatry 146: 576-584
15. Pearlman C (1987) High dose tranylcypromine in refractory depression. J Clin Psychiatry 48: 423-424 (letter)
16. Quitkin F, Rifkin A, Klein DF (1979) Monoamine oxidase inhibitors. A review of antidepressant effectiveness. Arch Gen Psychiatry 35: 749-760
17. Quitkin FM (1985) The importance of dosage in prescribing antidepressants. Br J Psychiatry 147: 593-597
18. Raskin A, Schulterbrandt JG, Reatig N et al (1974) Depression subtypes and response to phenelzine, diazepam and placebo. Arch Gen Psychiatry 30: 66-75
19. Robinson DS (1983) High-dose monoamine oxidase inhibitor therapy. J Am Med Assoc 250: 2212 (letter)
20. Sauer H, Lauter H (1987) Elektrokrampftherapie I. Wirksamkeit, Nebenwirkungen. Nervenarzt 58: 201-209
21. Schmauß M, Meller I (1989) Die "therapieresistente" Depression - Ursachen und Behandlungsmöglichkeiten. Psychiatr Prax 16: 101-108
22. Schmauß M, Erfurth A (1996) Kombinationstherapien bei Therapieresistenz auf Antidepressiva: Eine Übersicht. Fortschr Neurol Psychiat 64 (im Druck)
23. Shawcross C, Tyrer P (1987) The place of monoamine oxidase inhibitors in the treatment of resistant depression. In: Zohar J, Belmaker RH (eds) Treating resistant depression. PMA, New York, pp 113-129
24. Shopsin B, Kline NS (1976) Monoamine oxidase inhibitors: potential for drug abuse. Biol Psychiatry 11: 451-456
25. Stern SL, Mendels J (1981) Drug combinations in the treatment of refractory depression: a review. J Clin Psychiatry 42: 368-373
26. Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ (1992) Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors. J Clin Psychiatry 53: 5-11
27. Tollefson GD (1983) Monoamine oxidase inhibitors: a review. J Clin Psychiatry 44: 280-288
28. Tyrer P (1976) Towards rational therapy with monoamine inhibitors. Br J Psychiatry 128: 354-360
29. Varzopoulos D, Krull F (1991) Dependence on monoamine oxidase inhibitors in high dose. Br J Psychiatry 158: 856-857
30. Volz H-P, Faltus F, Magyar I, Möller H-J (1994) Brofaromine in treatment-resistant depressed patients: a comparative trial versus tranylcypromine. J Affective Disord 30: 209-217
31. White K, Simpson G (1985) Should the use of MAO inhibitors be abandonded. Integr Psychiatry 3: 34-45
32. Zisook S (1985) A clinical overview of monoamine oxidase inhibitors. Psychosomatics 26: 240-251